AzTrials
AzTrials

Profound AutismNCT07059364

Empowering Caregivers to Promote Child Independence

A study testing CAST Treatment in people with Profound Autism, run by University of Nebraska at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The proposed study aims to address the unique needs of caregivers and their adolescent children with profound autism. The constant supervision and 24/7 care that caregivers need to provide their children to ensure their health and safety often leaves little time for household duties, self-care routines, and spending… Read more about this study

Who is it for?
Ages 10 to 17 years
Conditions the study is for
Profound Autism
What is being tested?
CAST Treatment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
1 siteUnited States
Study dates
15 Jul 2025to Jul 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 10 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Autistic individuals 10 to 17 years of age
  • Severe or profound intellectual disability diagnosis or reportedly in line with diagnostic criteria based on Autism Diagnostic Observation Schedule, Second Edition ADOS-2
  • Developmental Profile 4 (DP-4) Cognitive/Communication Domain scores below 70 (Delayed)
  • Adaptive Behavior Assessment System (ABAS-3) Communication, Health and Safety, and Leisure Domains adaptive skill scores in the Low to Extremely Low range
  • Can complete between 3-10 simple leisure or daily living skill tasks or activities independently (caregiver may prompt or provide oversight)
  • Caregivers can remain present to assist with toileting if more than one person is needed to assist
Show all 9Show fewer
  • No medication or stable medication regimen with no planned changes for study duration
  • Stable intervention and/or educational services with no planned changes for study duration
  • English spoken by at least one caregiver

Who cannot join

  • Known serious medical condition or serious behavioral/psychiatric condition requiring immediate alternative focused intervention

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Alice Shillingsburg, PhD, BCBA-D contact

402-559-3098

ashillingsburg@unmc.edu

Emily Sullivan, PhD, BCBA-D contact

402-559-8863

esullivan@unmc.edu

United States1 site, 1 recruiting
  • Munroe-Meyer Insitute University of Nebraska Medical Center

    Omaha, Nebraska, 68106

    Amanda Oliver, MA, 402-552-3076, aoliver@unmc.edu

    Emily Sullivan, PhD, BCBA-D, 402-559-8863, esullivan@unmc.edu

    Recruiting

Other trials in United States

About this study

Official title: Empowering Caregivers to Promote Child Independence and Persistence With Activities

The proposed study aims to address the unique needs of caregivers and their adolescent children with profound autism. The constant supervision and 24/7 care that caregivers need to provide their children to ensure their health and safety often leaves little time for household duties, self-care routines, and spending time with family and friends. Investigators aim to alleviate the vigilant monitoring provided by caregivers for brief periods by increasing their child's independent, sustained engagement in meaningful activities and improving the quality of life for both adolescents with profound autism and their caregivers. Caregivers will either receive training to use picture-based activity schedules or continue with their usual routines. After the study, caregivers who continued their usual routines will also be offered the training. Investigators will evaluate the feasibility and acceptability of the training based on the children's performance, pre- and post-study improvement ratings, and caregiver feedback.

Read the detailed description

Approximately 25% of children with autism are estimated to meet the criteria for profound autism. Profound autism describes those with the greatest support needs because of the coinciding significant intellectual disability and limited/absent verbal communication. Because individuals with profound autism have been excluded from research, the investigator's understanding of effective assessments and interventions for this population and their families is incomplete. One defining feature associated with caring for a child with profound autism is the 24/7 supervision required from caregivers, often described as a feeling of constant vigilance. Although previous research on the matter may not use the specific term, profound autism, much can be gleaned from studies of caregivers with adult autistic children who cannot be left alone, autistic children with co-occurring intellectual disability, or older studies including children with IQ scores below 50 before autism was well understood. Caregivers facing these 24/7 obligations experience increased time constraints that prevent their self-care routines, limit time with family and friends, and reduce time spent on personal interests and work-related activities. Caregivers also report reduced time spent sleeping, preparing meals, and completing other household duties. Some report being unable to leave their child unattended for as little as 5 minutes. Relatedly, caregivers of profoundly autistic children report some of their greatest hopes for their children to be increased independence and autonomy to engage in enjoyable activities. Teaching autistic children how to engage appropriately with items can increase independent leisure engagement and increasing sustained activity engagement can promote autonomy and overall well-being. Therefore, interventions that promote independent, sustained engagement with activities could simultaneously benefit people with profound autism and their caregivers. However, characteristic restricted interests and repetitive behaviors can impede sustained activity engagement and interfere with transitioning to new activities. Thus, additional environmental supports, such as visuals, are sometimes needed. Picture-based activity schedules are an evidence-based practice that promotes sustained engagement with activities with reduced adult assistance. However, additional research is necessary to evaluate this intervention for individuals with profound autism and their caregivers.

The proposed study focuses on alleviating vigilant-level supervision provided by caregivers for brief periods while simultaneously increasing independent, sustained engagement with meaningful activities for their adolescent children with profound autism. Participants will randomly be assigned to either the Caregiver Activity Schedules Treatment (CAST) group and receive 40 hours of training in picture-based activities or be assigned to the Treatment as Usual (TAU) group. The TAU group will be offered CAST training following the trial. The feasibility, acceptability, and preliminary efficacy will be evaluated using measures of participant performance, participant affect, clinician ratings, and independent evaluation by an expert using the Clinical Global Impressions Improvement Scale (CGI-I).

Conditions
Profound Autism
Being tested
CAST Treatment
Keywords
Profound Autism, Picture-Based Activity Schedules, Caregiver Training

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CAST TreatmentBehavioural

    Activity completion will be evaluated based the number of consecutive and total activities completed, duration of sustained activity engagement, prompts or redirection, and adult proximity at baseline and post-trial.

Study groups in NCT07059364
Study groupRoleWhat they receive
Treatment as UsualNo interventionTreatment as Usual (TAU) will consist of 3-6 weeks of continuing usual care.
Caregiver Activity Schedules TreatmentExperimentalCaregiver Activity Schedules Treatment (CAST) consists of a picture-based activity schedule compiled into binders created for each participant. Activities for each participant will be selected with caregivers to include preference and feasibility. Activity steps include 1) opening the schedule/turning the page, 2) orienting to the picture, 3) retrieving the activity, 4) completing the activity, 5) putting the activity away, and 6) repeating each step until all activities are completed. Graduated guidance without verbal prompts will be used to support schedule completion. Implementer proximity will be faded within and between sessions. Caregivers will receive written descriptions of procedures. The researcher will describe and model all procedures and answer questions. Caregivers will implement procedures with their child and receive in-vivo feedback.
Receives: Behavioral: CAST Treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Participant Accrued

    Number of caregivers who accept random assignment as determined by refusal rate of eligible participants.

    Measured: Until accrual is complete, approximately 1 year

  2. Rate of Participant Attrition

    Participant attrition rate will be determined over the course of the study.

    Measured: Up to 6 weeks

  3. Ratings of Caregiver Activity Schedules Treatment Acceptability

    The acceptability of the Caregiver Activity Schedules Treatment (CAST) intervention by the caregiver will be measured using a 1 to 5 scale (anchored by 1 strongly disagree, and 5, strongly agree) by average ratings of agree (4) or strongly agree (5) to all acceptability rating scale statements and adolescents willingness to participate in intervention sessions.

    Measured: Up to 6 weeks

  4. Caregiver Reported Continued Use of Activity Schedules Treatment

    The reported continued use of the Caregiver Activity Schedules Treatment activity schedules at home by the caregiver will be determined at 6-weeks by responses to a 5 question open-ended questionaire.

    Measured: Up to 6 weeks

Secondary outcomes (7)
  1. Total Number of Activities Completed

    Caregiver Activity Schedules Treatment (CAST) activity completion will be evaluated based the number of total activities completed at baseline and post-trial.

    Measured: Baseline (enrollment) to end of treatment, up to 6 weeks

  2. Number of Consecutive Activities Completed

    Caregiver Activity Schedules Treatment (CAST) activity completion will be evaluated based the number of consecutive activities completed at baseline and post-trial.

    Measured: Baseline (enrollment) to end of treatment, up to 6 weeks

  3. Duration of Sustained Activity Engagement

    Caregiver Activity Schedules Treatment (CAST) activity completion will be evaluated based the duration of sustained activity engagement at baseline and post-trial.

    Measured: Baseline (enrollment) to end of treatment, up to 6 weeks

  4. Number of Prompts to Complete Activities

    Caregiver Activity Schedules Treatment (CAST) activity completion will be evaluated based the number of prompts needed to complete activities at baseline and post-trial.

    Measured: Baseline (enrollment) to end of treatment, up to 6 weeks

  5. Number of Redirections to Stay on Task

    Caregiver Activity Schedules Treatment (CAST) activity completion will be evaluated based the number of redirections to stay on task at baseline and post-trial.

    Measured: Baseline (enrollment) to end of treatment, up to 6 weeks

  6. Caregiver Proximity to Their Child

    Caregiver Activity Schedules Treatment (CAST) activity completion will be evaluated based the caregiver proximity to their child at baseline and post-trial.

    Measured: Baseline (enrollment) to end of treatment, up to 6 weeks

  7. Improvement Ratings on the Clinical Global Impressions - Improvement Scale

    The Clinical Global Impressions - Improvement Scale (CGI-I) is a 7-point scale designed to measure overall improvement from baseline. Scores range from 1 (Very Much Improved) to 7 (Very Much Worse). An independent evaluator (IE) will assess data recorded from direct observation (i.e., number of activities completed, duration of sustained engagement, amount and type of adult support provided) of the participant and caregiver at baseline and post-trial. Additionally, the IE will consider the baseline and post-trial Parent Target Problems (PTP) narratives which document caregiver-nominated target problems in specific areas of concern identified through conversation with caregivers. Using this information from baseline and post trial, the IE will yeild an improvement rating on the CGI-I.

    Measured: Baseline (enrollment) to end of treatment, up to 6 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Jul 2025
  2. Study start15 Jul 2025
  3. Primary completionJul 2027 (estimated)
  4. Study completionJul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly assigned to caregiver activity schedules training (CAST) or treatment as usual (TAU) in a 1:1 ratio according to permuted blocks. CAST consists of 40 hours of intervention in 2-hour appointments, 3-5 days/week, for 3-6 weeks. The appointment frequency and duration are intended to provide caregivers with flexibility and promote access to research. The TAU group will be offered CAST after their final assessment visit.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
32 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07059364
Sponsor's protocol ID
0708-24-FB
Other IDs
PRO-25-006
Status last verified
Aug 2026
First submitted
9 Jun 2025
Last updated
24 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All study outcome measures will be shared with the National Database for Autism Reserch. Global Unique Identifiers will be used to share data from the study and all indentifying participant information will be removed before sharing.

Publications

  • Scahill L, Shillingsburg MA, Ousley O, Pileggi ML, Kilbourne RL, Buckley D, Gillespie SE, McCracken C. A Randomized Trial of Direct Instruction Language for Learning in Children With Autism Spectrum Disorder. J Am Acad Child Adolesc Psychiatry. 2022 Jun;61(6):772-781. doi: 10.1016/j.jaac.2021.11.034. Epub 2022 Jan 31.

    PubMed 35093490
  • Bearss K, Johnson C, Smith T, Lecavalier L, Swiezy N, Aman M, McAdam DB, Butter E, Stillitano C, Minshawi N, Sukhodolsky DG, Mruzek DW, Turner K, Neal T, Hallett V, Mulick JA, Green B, Handen B, Deng Y, Dziura J, Scahill L. Effect of parent training vs parent education on behavioral problems in children with autism spectrum disorder: a randomized clinical trial. JAMA. 2015 Apr 21;313(15):1524-33. doi: 10.1001/jama.2015.3150.

    PubMed 25898050
  • Sheridan E, Gillespie S, Johnson CR, Lecavalier L, Smith T, Swiezy N, Turner K, Pritchett J, Mruzek DW, Evans AN, Bearss K, Scahill L. Using Parent Target Problem Narratives to Evaluate Outcomes in Children with Autism Spectrum Disorder. Res Child Adolesc Psychopathol. 2021 Nov;49(11):1527-1535. doi: 10.1007/s10802-021-00843-8. Epub 2021 Jul 2.

    PubMed 34213717
  • Hirst K, Zamzow RM, Stichter JP, Beversdorf DQ. A Pilot Feasibility Study Assessing the Combined Effects of Early Behavioral Intervention and Propranolol on Autism Spectrum Disorder (ASD). Children (Basel). 2023 Sep 30;10(10):1639. doi: 10.3390/children10101639.

    PubMed 37892301
  • Shillingsburg MA, Hansen B, Wright M. Rapport Building and Instructional Fading Prior to Discrete Trial Instruction: Moving From Child-Led Play to Intensive Teaching. Behav Modif. 2019 Mar;43(2):288-306. doi: 10.1177/0145445517751436. Epub 2018 Jan 17.

    PubMed 29338313
  • Gordon KR, Shillingsburg MA. Teaching mands for social information to individuals with develop mental disabilities. Adv Neurodev Disord. 2019;3;363-371. doi: 10.1007/s41252-019-00126-w

  • Frampton SE, Shillingsburg MA, Simeone PJ. Feasibility and Preliminary Efficacy of Direct Instruction for Individuals With Autism Utilizing Speech-Generating Devices. Behav Anal Pract. 2020 Feb 11;13(3):648-658. doi: 10.1007/s40617-020-00412-3. eCollection 2020 Sep.

    PubMed 32953393
  • Shillingsburg MA, Frampton SE, Juban B, Weddle SA, Silva MR. Implementing an applied verbal behavior model in classrooms. Behav Intervent. 2022;37(1), 56-78. doi.org/10.1002/bin.1807

  • Koyama T, Wang HT. Use of activity schedule to promote independent performance of individuals with autism and other intellectual disabilities: a review. Res Dev Disabil. 2011 Nov-Dec;32(6):2235-42. doi: 10.1016/j.ridd.2011.05.003. Epub 2011 Jun 6.

    PubMed 21645988
  • Lequia J, Machalicek W, Rispoli MJ. Effects of activity schedules on challenging behavior exhibited in children with autism spectrum disorders: A systematic review. Res Autism Spectr Disord. 2012;6(1); 480- 492. doi: 10.1016/j.rasd.2011.07.008

  • . Cho S, Noor NHBM, Sonoyama S. A review of activity schedules for individuals with autism spectrum disorder. J of Spec Educ Resear. 2017;5(2):65-76. doi:10.6033/specialeducation.5.65

  • Cavalari RN, Romanczyk RG. Caregiver perspectives on unintentional injury risk in children with an autism spectrum disorder. J Pediatr Nurs. 2012 Dec;27(6):632-41. doi: 10.1016/j.pedn.2011.07.013. Epub 2011 Sep 13.

    PubMed 23101727
  • Knight V, Sartini E, Spriggs AD. Evaluating visual activity schedules as evidence-based practice for individuals with autism spectrum disorders. J Autism Dev Disord. 2015 Jan;45(1):157-78. doi: 10.1007/s10803-014-2201-z.

    PubMed 25081593
  • Lang R., O'Reilly M, Rispoli M, Shogren K., Machalicek W, Sigafoos J, Regester A. Review of interventions to increase functional and symbolic play in children with autism. Educ and Train in Dev Disab. 2009;44;481-492. https://www.jstor.org/stable/24234257

  • Schwartz IS, Kelly EM. Quality of life for people with disabilities: Why applied behavior analysts should consider this a primary dependent variable. Resear and Pract Severe Disabil. 2021;46(3);159-172. doi.org/10.1177/15407969211033629

Questions about this trial

What is this clinical trial studying?

A study testing CAST Treatment in people with Profound Autism, run by University of Nebraska at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 24 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Alice Shillingsburg, PhD, BCBA-D (402-559-3098, ashillingsburg@unmc.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Participant Accrued (time frame: Until accrual is complete, approximately 1 year). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07059364, which also lists 23 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in